170 related articles for article (PubMed ID: 28756742)
1. Pentablock copolymer dexamethasone nanoformulations elevate MYOC: in vitro liberation, activity and safety in human trabecular meshwork cells.
Agrahari V; Li G; Agrahari V; Navarro I; Perkumas K; Mandal A; Stamer WD; Mitra AK
Nanomedicine (Lond); 2017 Aug; 12(16):1911-1926. PubMed ID: 28756742
[TBL] [Abstract][Full Text] [Related]
2. Differential response and withdrawal profile of glucocorticoid-treated human trabecular meshwork cells.
Li G; Cui G; Dismuke WM; Navarro I; Perkumas K; Woodward DF; Stamer WD
Exp Eye Res; 2017 Feb; 155():38-46. PubMed ID: 27939447
[TBL] [Abstract][Full Text] [Related]
3. NFATc1 activity regulates the expression of myocilin induced by dexamethasone.
Faralli JA; Clark RW; Filla MS; Peters DM
Exp Eye Res; 2015 Jan; 130():9-16. PubMed ID: 25450062
[TBL] [Abstract][Full Text] [Related]
4. Reduced myocilin expression in cultured monkey trabecular meshwork cells induced by a selective glucocorticoid receptor agonist: comparison with steroids.
Pfeffer BA; DeWitt CA; Salvador-Silva M; Cavet ME; López FJ; Ward KW
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):437-46. PubMed ID: 19696178
[TBL] [Abstract][Full Text] [Related]
5. Tissue differential microarray analysis of dexamethasone induction reveals potential mechanisms of steroid glaucoma.
Lo WR; Rowlette LL; Caballero M; Yang P; Hernandez MR; Borrás T
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):473-85. PubMed ID: 12556371
[TBL] [Abstract][Full Text] [Related]
6. Analysis of glucocorticoid-induced MYOC expression in human trabecular meshwork cells.
Joe MK; Sohn S; Kim TE; Im JE; Choi YR; Kee C
Vision Res; 2011 May; 51(9):1033-8. PubMed ID: 21334360
[TBL] [Abstract][Full Text] [Related]
7. Regulation of myocilin-associated exosome release from human trabecular meshwork cells.
Hoffman EA; Perkumas KM; Highstrom LM; Stamer WD
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1313-8. PubMed ID: 18952916
[TBL] [Abstract][Full Text] [Related]
8. Composite Nanoformulation Therapeutics for Long-Term Ocular Delivery of Macromolecules.
Agrahari V; Agrahari V; Hung WT; Christenson LK; Mitra AK
Mol Pharm; 2016 Sep; 13(9):2912-22. PubMed ID: 26828415
[TBL] [Abstract][Full Text] [Related]
9. Delayed secondary glucocorticoid responsiveness of MYOC in human trabecular meshwork cells.
Shepard AR; Jacobson N; Fingert JH; Stone EM; Sheffield VC; Clark AF
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3173-81. PubMed ID: 11726619
[TBL] [Abstract][Full Text] [Related]
10. In vitro localization of TIGR/MYOC in trabecular meshwork extracellular matrix and binding to fibronectin.
Filla MS; Liu X; Nguyen TD; Polansky JR; Brandt CR; Kaufman PL; Peters DM
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):151-61. PubMed ID: 11773026
[TBL] [Abstract][Full Text] [Related]
11. Functional delivery of synthetic naked siRNA to the human trabecular meshwork in perfused organ cultures.
Comes N; Borrás T
Mol Vis; 2007 Aug; 13():1363-74. PubMed ID: 17768383
[TBL] [Abstract][Full Text] [Related]
12. Effects of timolol on MYOC, OPTN, and WDR36 RNA levels.
Rozsa FW; Scott K; Pawar H; Moroi S; Richards JE
Arch Ophthalmol; 2008 Jan; 126(1):86-93. PubMed ID: 18195223
[TBL] [Abstract][Full Text] [Related]
13. mRNA in situ hybridization of TIGR/MYOC in human trabecular meshwork.
Wang X; Johnson DH
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1724-9. PubMed ID: 10845592
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues.
Clark AF; Steely HT; Dickerson JE; English-Wright S; Stropki K; McCartney MD; Jacobson N; Shepard AR; Clark JI; Matsushima H; Peskind ER; Leverenz JB; Wilkinson CW; Swiderski RE; Fingert JH; Sheffield VC; Stone EM
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1769-80. PubMed ID: 11431441
[TBL] [Abstract][Full Text] [Related]
15. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning of the bovine MYOC and induction of its expression in trabecular meshwork cells.
Taniguchi F; Suzuki Y; Kurihara H; Kurihara Y; Kasai H; Shirato S; Araie M
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2070-5. PubMed ID: 10892845
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: a novel application in pediatric nanomedicine.
Krishnan V; Xu X; Barwe SP; Yang X; Czymmek K; Waldman SA; Mason RW; Jia X; Rajasekaran AK
Mol Pharm; 2013 Jun; 10(6):2199-210. PubMed ID: 23194373
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone induces specific proteins in human trabecular meshwork cells.
Partridge CA; Weinstein BI; Southren AL; Gerritsen ME
Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1843-7. PubMed ID: 2759798
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone and Glucocorticoid-Induced Matrix Temporally Modulate Key Integrins, Caveolins, Contractility, and Stiffness in Human Trabecular Meshwork Cells.
Yemanyi F; Baidouri H; Burns AR; Raghunathan V
Invest Ophthalmol Vis Sci; 2020 Nov; 61(13):16. PubMed ID: 33170205
[TBL] [Abstract][Full Text] [Related]
20. Low dose latrunculin-A inhibits dexamethasone-induced changes in the actin cytoskeleton and alters extracellular matrix protein expression in cultured human trabecular meshwork cells.
Liu X; Wu Z; Sheibani N; Brandt CR; Polansky JR; Kaufman PL
Exp Eye Res; 2003 Aug; 77(2):181-8. PubMed ID: 12873448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
